Ken O'Flynn
Ceist:548. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 315 of 11 February 2025, and noting that the National Centre for Pharmacoeconomics completed a full health technology assessment of tirzepatide for the treatment of adults with insufficiently controlled type 2 diabetes mellitus on 9 February 2026, and for weight management on 3 December 2025, whether she has been notified of the completion of those assessments; the month in 2026 in which the HSE senior leadership team is scheduled to consider each application for pricing and reimbursement; whether any internal target decision date has been set by her Department or the HSE; and if she will make a statement on the matter. [15874/26]
Amharc ar fhreagra